Belite Bio Inc

BLTE | NASDAQ

Price Alert Chart Builder DCF Calculator

$175.17

+$1.77 (+1.02%)

Sep 22, 2026, 2:05 PM ET · Market open

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Pro Subscription

Upgrade now for unlimited access to all data, tools and no ads.

Upgrade now ➞

Related Stocks

Company	Yield
ACAD ACADIA Pharmaceuticals	N/A
ADMA ADMA Biologics	N/A
ARQT Arcutis Biotherapeutics	N/A
DYN Dyne Therapeutics	N/A
LGND Ligand Pharmaceuticals Incorporated	N/A
MIRM Mirum Pharmaceuticals	N/A
PRAX Praxis Precision Medicines	N/A
VKTX Viking Therapeutics	N/A

Dividend Rankings ➞

Recent News

8 days ago / seekingalpha.com
Belite Bio, Inc (BLTE) Presents at Morgan Stanley 24th Annual Global Healthcare Conference Transcript
13 days ago / zacks.com
Belite Bio, Inc. Sponsored ADR (BLTE)'s Technical Outlook is Bright After Key Golden Cross
15 days ago / globenewswire.com
Belite Bio Announces Submission of New Drug Application to the Ministry of Health, Labour, and Welfare in Japan under the Sakigake Designation System for Tinlarebant for the Treatment of Stargardt Disease Type 1
18 days ago / benzinga.com
Why Is Belite Bio Stock Soaring Friday?
20 days ago / seekingalpha.com
Belite Bio, Inc (BLTE) Discusses Prelaunch Strategy and Commercial Opportunity for Tinlarebant in Stargardt Disease Type 1 Transcript
21 days ago / globenewswire.com
Belite Bio to Participate in Four Upcoming Investor Conferences
29 days ago / globenewswire.com
Belite Bio to Host Virtual Commercial Day on September 2, 2026
1 month ago / globenewswire.com
Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
1 month ago / seekingalpha.com
Belite Bio, Inc (BLTE) Q2 2026 Earnings Call Transcript
1 month ago / marketbeat.com
Belite Bio Q2 Earnings Call Highlights